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Prescription opioid analgesics are used to treat pain resulting from a variety of health conditions, 
surgery, and injury. However, opioid-related deaths have emerged as a public health issue (1), 
and efforts to monitor prescription opioid analgesic use are ongoing (2,3). This analysis uses 
data from the National Health and Nutrition Examination Survey (NHANES) to examine the 
prevalence (age adjusted for race and Hispanic-origin estimates) of prescription opioid analgesic 
use among U.S. adults. 
During 2013–2016, 6.5% of adults aged 20 and over reported using a prescription opioid 
analgesic in the past 30 days (Figure 1, Table).
The percentage of adults who used a prescription opioid analgesic increased with age, from 
3.2% among younger adults aged 20–39, to 7.5% among middle-aged adults 40–59, and to 9.6% 
among adults aged 60 and over. This pattern was observed for men and women.
A higher percentage of women (7.6%) compared with men (5.3%) used a prescription opioid 
analgesic. This pattern was also seen within each age group, although the difference among 
adults aged 20–39 was not significant.
Age-adjusted opioid analgesic use was highest among non-Hispanic white (6.6%) and non-
Hispanic black (6.7%) adults compared with non-Hispanic Asian (2.0%) and Hispanic (5.3%) 
adults (Figure 2). Use was higher among Hispanic adults compared with non-Hispanic Asian 
adults. The percentage of non-Hispanic white (7.7%) and non-Hispanic black (8.4%) women 
using an opioid analgesic was higher compared with non-Hispanic Asian (2.4%) and Hispanic 
(5.8%) women. Use was higher among Hispanic women compared with non-Hispanic Asian 
women. However, among men, there were no significant differences among non-Hispanic white 
(5.4%), non-Hispanic black (4.6%), and Hispanic (4.7%) men. A higher percentage of non-
Hispanic white women and non-Hispanic black women used an opioid analgesic compared with 
men in the same race and Hispanic-origin groups.
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Data source and methods
NHANES, conducted by the National Center for Health Statistics (NCHS), is a multistage 
probability survey of the civilian noninstitutionalized population of the United States (4). Each 
survey participant completes a household interview and a physical examination. During the 
household interview, survey participants were asked if they had taken a prescription medication 
in the past 30 days. Those who answered “yes” were asked to show the interviewer the 
medication containers of all prescription medications. For each drug reported, the interviewer 
recorded the product’s complete name from the container or a pharmacy print out. NCHS used 
Cerner Multum Lexicon’s therapeutic classification scheme to classify prescription medications 
(5).
Interview sample weights, which accounted for the differential probabilities of selection, 
nonresponse, and noncoverage, were incorporated into the estimation process. Taylor series 
linearization was used to compute variance estimates. Differences between subgroups and linear 
trends were evaluated using orthogonal contrasts to calculate a Student’s t statistic. Differences 
were considered significant at p < 0.05. All reported estimates, except the estimate for non-
Hispanic Asian men, met NCHS reliability standards (6). Estimates by race and Hispanic origin 
were age adjusted using the direct method to the 2000 projected U.S. population using the age 
groups 20–39, 40–59, and 60 and over (7). 
Study methods, including variable design, are based on prior research (8).
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1Significant difference between men and women in the same age group.  
NOTE: Significant increasing linear trend by age group. 
SOURCE: NCHS, National Health and Nutrition Examination Survey, 2013–2016.
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Figure 1. Crude percentage of adults aged 20 and over who used a prescription opioid analgesic in the past 30 days, by sex and 
age: United States, 2013–2016
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1Significantly different from Hispanic persons.
2Significantly different from non-Hispanic Asian persons.
3Significant difference between men and women in the same race and Hispanic-origin group.
4Estimate does not meet NCHS reliability standards.  
NOTE: All estimates are age adjusted by the direct method to the 2000 projected U.S. population using the age groups 20–39, 40–59, and 60 and over. 
SOURCE: NCHS, National Health and Nutrition Examination Survey, 2013–2016.
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Figure 2. Age-adjusted percentage of adults aged 20 and over who used a prescription opioid analgesic in the past 30 days, by sex 
and race and Hispanic origin: United States, 2013–2016
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Table. Crude and age-adjusted prevalence rates of prescription opioid analgesic 
use, in the past 30 days, among adults aged 20 and over: United States, 2013–2016
Sex, age group, race and Hispanic origin Sample size (n) Percent (95% CI)
Crude estimate
Overall:
20 and over 761 6.5 (5.7, 7.4)
20–39 124 3.2 (2.5, 4.0)
40–59 270 7.5 (5.9, 9.2)
60 and over 367 9.6 (8.0, 11.4)
Men:
20 and over 316 5.3 (4.2, 6.7)
20–39 50 2.6 (1.8, 3.8)
40–59 109 6.2 (4.3, 8.6)
60 and over 157 7.9 (6.0, 10.3)
Women:
20 and over 445 7.6 (6.7, 8.6)
20–39 74 3.8 (2.7, 5.1)
40–59 161 8.7 (7.1, 10.4)
60 and over 210 11.0 (8.9, 13.4)
Age-adjusted estimate
Overall:
Non-Hispanic white 357 6.6 (5.6, 7.7)
Non-Hispanic black 170 6.7 (5.8, 7.7)
Non-Hispanic Asian 27 2.0 (1.0, 3.5)
Hispanic 166 5.3 (4.3, 6.4)
Men:
Non-Hispanic white 150 5.4 (3.9, 7.2)
Non-Hispanic black 62 4.6 (3.6, 5.8)
Non-Hispanic Asian 9 *1.4 (0.4, 3.3)
Hispanic 71 4.7 (3.7, 5.9)
Women:
Non-Hispanic white 207 7.7 (6.6, 9.0)
Non-Hispanic black 108 8.4 (7.2, 9.6)
Non-Hispanic Asian 18 2.4 (1.2, 4.3)
Hispanic 95 5.8 (4.5, 7.3)
*Estimate does not meet NCHS standards of reliability.
NOTES: CI is confidence interval. Prevalence estimates are age adjusted by the direct method to 
the projected 2000 U.S. census population using the age groups 20–39, 40–59, and 60 and over. 
The age-adjusted estimates for adults of other race and Hispanic-origin groups are not provided 
separately, but members of these groups are included in the overall crude estimate.
SOURCE: NCHS, National Health and Nutrition Examination Survey, 2013–2016.
